Extract from “Medicine prices will remain high under TPPA, says Klang MP”

Santiago said American-based multinational company Johnson and Johnson, which had played a significant role in the preparation of the TPPA text, had spent US$8.2 billion (RM36.14 billion) on research and development for medicines, but doubled its budget on sales and marketing at US$17.5 billion (RM77.14 billion).

“The excuse they always give is that ‘we need to make more profit so that there is more innovation, so that is why we want to extend the patent protection period’.

“But this argument makes no sense because they spend double that amount on sales and marketing,”

Loading data

Welcome to TPP Debate!
What's your stance?

TPPDebate.org is a crowd-sourced platform to debate the Trans-Pacific Partnership Agreement (TPP). What does everyone think about the TPP? What is your stance?